Tofacitinib
- Strength
- 5 mg/1
- Form
- Tablet, Film Coated
- Class
- Janus Kinase Inhibitor
AvKARE
Listed by Micro Labs Limited
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Janus Kinase Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 42571-268 |
| FDA application | ANDA209738 |
| RxNorm concept | 1357541 |
| Package sizes listed | 4 |
| Marketed since | June 2026 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
AvKARE
Macleods Pharmaceuticals Limited
Micro Labs Limited
Edenbridge Pharmaceuticals LLC.
Apotex Corp.
Zydus Lifesciences Limited
Orient Pharma Co., Ltd. Yunlin Plant
Exelan pharmaceuticals,Inc
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.